Pharmacokinetics of Dapivirine Transfer into Blood Plasma, Breast Milk, and Cervicovaginal Fluid of Lactating Women Using the Dapivirine Vaginal Ring

Authors:

Abstract
Breastfeeding (BF) women are an important population for biomedical HIV prevention strategies, but they are rarely included in trials. The 25-mg dapivirine vaginal ring (VR) reduced women’s risk of sexually transmitted HIV infection in two phase 3 trials conducted in Africa.
Funding Information
  • National Institutes of Health (5UM1 AI 068633)
  • HHS | National Institutes of Health (5UM1 AI 106707)
  • HHS | National Institutes of Health (5UM1 AI 068815)

This publication has 13 references indexed in Scilit: